The rising interest in GLP-1 drugs for diabetes has sparked a debate about delivery routes : patches versus capsules. Typically, GLP-1 treatments were solely available in tablet form, but the emergence of patches provides a new choice . Transdermal systems might be advantageous for individuals with difficulty with pills , those wanting to reduce fi